• High Quality Sorafenib Tosylate Pharmaceutical Intermediates for Anti-Turmor CAS 284461-73-0
  • High Quality Sorafenib Tosylate Pharmaceutical Intermediates for Anti-Turmor CAS 284461-73-0
  • High Quality Sorafenib Tosylate Pharmaceutical Intermediates for Anti-Turmor CAS 284461-73-0
  • High Quality Sorafenib Tosylate Pharmaceutical Intermediates for Anti-Turmor CAS 284461-73-0
  • High Quality Sorafenib Tosylate Pharmaceutical Intermediates for Anti-Turmor CAS 284461-73-0
  • High Quality Sorafenib Tosylate Pharmaceutical Intermediates for Anti-Turmor CAS 284461-73-0

High Quality Sorafenib Tosylate Pharmaceutical Intermediates for Anti-Turmor CAS 284461-73-0

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
State: Powder
Purity: >98%
Samples:
US$ 77/gram 1 gram(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2021

Suppliers with verified business licenses

Rating: 5.0/5
Manufacturer/Factory

Basic Info.

Model NO.
sorafenib
Color
White Crystalline Powder
Density
1.454
Molecular Formula
C21h16clf3n4o3
Formula Weight
464.825
CAS
284461-73-0
Storage Condition
Seal and Store in a Cool, Dry Place
Transport Package
Aluminium Foil Bag and Carton
Specification
98% sorafenib
Trademark
HNB
Origin
China
HS Code
2933322000
Production Capacity
25 Mt/Month

Product Description

High Quality Sorafenib Tosylate Pharmaceutical Intermediates for Anti-Turmor CAS 284461-73-0
High Quality Sorafenib Tosylate Pharmaceutical Intermediates for Anti-Turmor cas 284461-73-0
 

Name  :     sorafenib
Shape :     White crystalline powder

Use for :   
                
1. Sorafenib is a novel multi-targeted antitumor drug that acts on both tumor cells and tumor blood vessels. It has dual anti-tumor effects: it can directly inhibit tumor cell proliferation by blocking the cell signaling pathway mediated by RAF/MEK/ERK, and indirectly inhibit tumor cell growth by blocking the formation of tumor neovascularization through inhibiting VE GF and platelet-derived growth fact or (PD GF) receptors.
               2. Sorafenib is a novel multi-targeted oral drug for the treatment of tumors
               3. Multiple kinase inhibitor targeting both RAF kinase and receptor tyrosine kinases that promote angiogensis. Antineoplastic.

                     
 

             

                Sorafenib is a new multitarget oral drug for the treatment of cancer. It is used to treat gastrointestinal stromal tumors and metastatic kidney cells that do not respond to or tolerate standard therapies. It selectively targets certain protein receptors and is thought to act as a molecular switch during tumor growth.

Name CAS molecular density
Sorafenib 284461-73-0 C21H16ClF3N4O3 1.454
 
High Quality Sorafenib Tosylate Pharmaceutical Intermediates for Anti-Turmor CAS 284461-73-0           High Quality Sorafenib Tosylate Pharmaceutical Intermediates for Anti-Turmor CAS 284461-73-0

 

 

High Quality Sorafenib Tosylate Pharmaceutical Intermediates for Anti-Turmor CAS 284461-73-0

 

High Quality Sorafenib Tosylate Pharmaceutical Intermediates for Anti-Turmor CAS 284461-73-0High Quality Sorafenib Tosylate Pharmaceutical Intermediates for Anti-Turmor CAS 284461-73-0

High Quality Sorafenib Tosylate Pharmaceutical Intermediates for Anti-Turmor CAS 284461-73-0

High Quality Sorafenib Tosylate Pharmaceutical Intermediates for Anti-Turmor CAS 284461-73-0High Quality Sorafenib Tosylate Pharmaceutical Intermediates for Anti-Turmor CAS 284461-73-0High Quality Sorafenib Tosylate Pharmaceutical Intermediates for Anti-Turmor CAS 284461-73-0High Quality Sorafenib Tosylate Pharmaceutical Intermediates for Anti-Turmor CAS 284461-73-0

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

Find Similar Products By Category

Supplier Homepage Products API for Human Others API for Human High Quality Sorafenib Tosylate Pharmaceutical Intermediates for Anti-Turmor CAS 284461-73-0